176 related articles for article (PubMed ID: 23590208)
1. Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.
Ghosh P; Brogden NK; Stinchcomb AL
Mol Pharm; 2013 Jun; 10(6):2331-9. PubMed ID: 23590208
[TBL] [Abstract][Full Text] [Related]
2. Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.
Ghosh P; Lee D; Kim KB; Stinchcomb AL
Pharm Res; 2014 Jan; 31(1):148-59. PubMed ID: 23943543
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin.
Milewski M; Pinninti RR; Stinchcomb AL
J Pharm Sci; 2012 Aug; 101(8):2777-86. PubMed ID: 22628183
[TBL] [Abstract][Full Text] [Related]
4. Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
Banks SL; Pinninti RR; Gill HS; Crooks PA; Prausnitz MR; Stinchcomb AL
Pharm Res; 2008 Jul; 25(7):1677-85. PubMed ID: 18449628
[TBL] [Abstract][Full Text] [Related]
5. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
Milewski M; Stinchcomb AL
Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
[TBL] [Abstract][Full Text] [Related]
6. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL
J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989
[TBL] [Abstract][Full Text] [Related]
7. Transdermal Delivery of Cimetidine Across Microneedle-Treated Skin: Effect of Extent of Drug Ionization on the Permeation.
Song Y; Herwadkar A; Patel MG; Banga AK
J Pharm Sci; 2017 May; 106(5):1285-1292. PubMed ID: 28161442
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.
Brogden NK; Banks SL; Crofford LJ; Stinchcomb AL
Pharm Res; 2013 Aug; 30(8):1947-55. PubMed ID: 23761054
[TBL] [Abstract][Full Text] [Related]
9. Development of a codrug approach for sustained drug delivery across microneedle-treated skin.
Ghosh P; Pinninti RR; Hammell DC; Paudel KS; Stinchcomb AL
J Pharm Sci; 2013 May; 102(5):1458-67. PubMed ID: 23417751
[TBL] [Abstract][Full Text] [Related]
10. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
Milewski M; Brogden NK; Stinchcomb AL
Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
[TBL] [Abstract][Full Text] [Related]
11. Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.
Yerramreddy TR; Milewski M; Penthala NR; Stinchcomb AL; Crooks PA
Bioorg Med Chem Lett; 2010 Jun; 20(11):3280-3. PubMed ID: 20451376
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.
Banks SL; Pinninti RR; Gill HS; Paudel KS; Crooks PA; Brogden NK; Prausnitz MR; Stinchcomb AL
J Pharm Sci; 2010 Jul; 99(7):3072-80. PubMed ID: 20166200
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin.
Ghosh P; Brogden NK; Stinchcomb AL
J Pharm Sci; 2014 Feb; 103(2):652-60. PubMed ID: 24395718
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency.
Tobin KV; Brogden NK
Biomater Sci; 2023 Aug; 11(17):5846-5858. PubMed ID: 37455601
[TBL] [Abstract][Full Text] [Related]
15. Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin.
Patel KK; Brogden NK
Pharm Res; 2024 Feb; 41(2):355-363. PubMed ID: 38133717
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.
Eldridge JA; Milewski M; Stinchcomb AL; Crooks PA
Bioorg Med Chem Lett; 2014 Nov; 24(22):5212-5. PubMed ID: 25442314
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of skin resealing after insertion of microneedles in human subjects.
Gupta J; Gill HS; Andrews SN; Prausnitz MR
J Control Release; 2011 Sep; 154(2):148-55. PubMed ID: 21640148
[TBL] [Abstract][Full Text] [Related]
18. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R; Bokalial R; Sharma P; Khandavilli S
Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
[TBL] [Abstract][Full Text] [Related]
20. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin.
Thakkar HP; Savsani H; Kumar P
Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]